The emerging role of cardiovascular MRI for risk stratification in hypertrophic cardiomyopathy

E T D Hoey1, J K Teoh2, I Das1

  • 1Department of Radiology, Heart of England NHS Foundation Trust, Birmingham, West Midlands, UK.

Clinical Radiology
|January 14, 2014
PubMed

Insights

Hypertrophic cardiomyopathy (HCM) is a genetic heart condition. Cardiovascular magnetic resonance imaging (CMR) aids in risk stratification for sudden death (SD) by assessing myocardial fibrosis and hypertrophy.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Genetics

Background:

  • Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiovascular disease.
  • Sudden death (SD) can be the first sign of HCM, often linked to arrhythmias caused by myocardial disorganization and scarring.
  • Echocardiography may be inconclusive, necessitating advanced imaging techniques.

Purpose of the Study:

  • To review the role of Cardiovascular Magnetic Resonance imaging (CMR) in risk stratification for sudden death (SD) in patients with Hypertrophic Cardiomyopathy (HCM).
  • To highlight CMR's ability to assess key indicators of adverse prognosis in HCM.

Main Methods:

  • Utilizes Cardiovascular Magnetic Resonance imaging (CMR) for non-invasive assessment.
  • Employs inversion recovery gadolinium-enhanced sequences to evaluate myocardial fibrosis.
  • Assesses biventricular function and wall thickness.

Main Results:

  • CMR provides precise assessment of biventricular function, wall thickness, and myocardial fibrosis.
  • Recent research using CMR has identified potential adverse prognostic indicators for SD in HCM.
  • CMR findings offer insights into the electrophysiological substrate of HCM.

Conclusions:

  • CMR is crucial for diagnosing HCM and assessing risk, especially when echocardiography is inconclusive.
  • CMR is a promising research tool, identifying new prognostic indicators for SD.
  • Integrating CMR findings into existing risk algorithms is essential for improved patient management.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
952
Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
541
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
826
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
973